 |
|
|
| |
Meta-Analysis of the Real-World Effectiveness of Ombitasvir/Paritaprevir ritonavir ± Dasabuvir ± Ribavirin in Patients With HCV Genotype 1 or 4 Infection
|
| |
| |
Reported by Jules Levin
EASL Paris Special Meeting - Roadmap for a Cure Sept 23-24 2016
Heiner Wedemeyer1, Antonio Craxi2, Eli Zuckerman3, Douglas Dieterich4, Robert Flisiak5, Stuart K Roberts6, Andreas Pangerl7, Zhenzhen Zhang7, Marisol Martinez7, Yanjun Bao7, Jose-Luis Calleja8 1Medizinische Hochschule Hannover, Hannover, Germany; 2AOU Policlinico "P Giaccone" Dip Di Gastroenterologia ed Epatologia DBMIS, Palermo, Italy; 3Carmel Medical Center Liver Institute, Haifa, Israel; 4Mount Sinai Hospital, New York, New York, United States; 5Klinika Chorob Zakaznych i Hepatologii UM w Bialymstoku, Bialystok, Poland; 6Alfred Hospital and Monash University, Melbourne, Victoria, Australia; 7AbbVie Inc., North Chicago, Illinois, United States; 8Hospital Universitario Puerta de Hierro, Universidad Autonoma de Madrid, Madrid, Spain
|
| |
|
|
|
|
|
